tiprankstipranks
Kissei Pharmaceutical Co Ltd (KSPHF)
OTHER OTC:KSPHF
US Market
KSPHF
Kissei Pharmaceutical Co
RESEARCH TOOLSreports
Want to see KSPHF full AI Analyst Report?

Kissei Pharmaceutical Co (KSPHF) Income Statement

11 Followers

Kissei Pharmaceutical Co Income Statement

Last quarter (Q4 2025), Kissei Pharmaceutical Co's total revenue was ¥22.66B, an increase of 2.12% from the same quarter last year. In Q4, Kissei Pharmaceutical Co's net income was ¥3.12B. See Kissei Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Mar 26Mar 25Mar 24Mar 23Mar 22
Total Revenue
¥ 88.33B¥ 75.58B¥ 67.49B¥ 65.38B¥ 69.04B
Gross Profit
¥ 44.06B¥ 37.34B¥ 32.38B¥ 31.24B¥ 32.72B
Operating Expenses
¥ 38.29B¥ 33.32B¥ 33.50B¥ 32.64B¥ 31.22B
Depreciation and Amortization
¥ 4.62B¥ 4.25B¥ 4.11B¥ 3.73B¥ 3.15B
EBITDA
¥ 20.25B¥ 18.72B¥ 17.81B¥ 20.26B¥ 10.65B
Operating Income
¥ 5.77B¥ 4.02B¥ -1.13B¥ -1.40B¥ 1.50B
Other Income/Expenses
¥ 9.84B¥ 10.43B¥ 14.81B¥ 17.91B¥ 5.97B
Pretax Income
¥ 15.61B¥ 14.45B¥ 13.68B¥ 16.51B¥ 7.48B
Net Income
¥ 11.96B¥ 11.16B¥ 10.53B¥ 12.92B¥ 5.29B
Per Share Metrics
Basic EPS
¥ 274.20¥ 246.58¥ 228.30¥ 280.19¥ 113.25
Diluted EPS
¥ 274.20¥ 246.58¥ 228.30¥ 280.19¥ 113.25
Weighted Average Shares Outstanding
 43.62M 45.26M 46.12M 46.12M 46.67M
Weighted Average Shares Outstanding (Diluted)
 43.62M 45.26M 46.12M 46.12M 46.67M
Currency in JPY

Kissei Pharmaceutical Co Earnings and Revenue History